REQUEST A DEMO
Total
USD $0.00
Search more companies

Innventa Pharm D.O.O. (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Innventa Pharm D.O.O. Profile Updated: October 13, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Innventa Pharm D.O.O. is based in Serbia, with the head office in Belgrade. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. Innventa Pharm D.O.O. was incorporated on 2011. 26 (2020) employees currently work for Innventa Pharm D.O.O.. In 2022, the company reported a net sales revenue drop of 22.53%. Its’ total assets recorded a growth of 53.98%. In, 2022, the company’s net profit margin decreased by 6.56%.

Headquarters
Sumatovacka 36
Belgrade; Belgrade; Postal Code: 11104

Contact Details: Purchase the Innventa Pharm D.O.O. report to view the information.

Website: http://www.innventa-pharm.com

Basic Information
Total Employees:
Purchase the Innventa Pharm D.O.O. report to view the information.
Outstanding Shares:
Purchase the Innventa Pharm D.O.O. report to view the information.
Registered Capital:
Purchase the Innventa Pharm D.O.O. report to view the information.
Incorporation Date:
2011
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
70%
Purchase this report to view the information.
30%
Company Performance
Financial values in the chart are available after Innventa Pharm D.O.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
-22.53%
Total operating revenue
-22.64%
Operating profit (EBIT)
-74.1%
EBITDA
-69.64%
Net Profit (Loss) for the Period
-81.32%
Total assets
53.98%
Total equity
-1.81%
Operating Profit Margin (ROS)
-13.88%
Net Profit Margin
-6.56%
Return on Equity (ROE)
-25.9%
Debt to Equity Ratio
126.64%
Quick Ratio
0.13%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?